Back to SUSQUEHANNA INTERNATIONAL GROUP, LLP SUSQUEHANNA INTERNATIONAL GROUP, LLP

QNCXQNCX
Showing 5 of 19 quarters

Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLPSUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in QUINCE THERAPEUTICS INC

As of its Q1 2026 13F, Susquehanna International Group held 172,640 shares of QNCX (Quince Therapeutics), worth $17,506. Susquehanna International Group's 13F filings listed QNCX from Q4 2025 to Q1 2026, 2 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$25,268

Total Shares Change

-32,553

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$18.19
0
2026-Q1
Decreased
172,640
-50.0%
$17,5060.0%$20.20
0
2025-Q4
New
345,095
-
$1.2M0.0%$670.00
35
2024-Q4
Exited
0
-100.0%
$00.0%$374.00
0
2024-Q3
Decreased
32,553
-67.0%
$25,2680.0%$155.20
0

Other major holders of QNCX: Capital World Investors, Capital International Investors, Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used